Purinergic signaling mediated by P2X7 receptors controls myelination in sciatic nerves

Journal of Neuroscience Research

Volumn 92, Issue 10, 2014, Pages 1259-1269

  Faroni, A ^a   Smith, R J P ^a   Procacci, P ^b   Castelnovo, L F ^b   Puccianti, E ^b   Reid, A J ^a   Magnaghi, V ^b   Verkhratsky, A ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

ATP; Cell fate; Myelin; P2X; Schwann cells; Sciatic nerve

Indexed keywords

MESSENGER RNA; MYELIN ASSOCIATED GLYCOPROTEIN; PURINERGIC P2X7 RECEPTOR; ARABIDOPSIS PROTEIN; MARNERAL SYNTHASE, ARABIDOPSIS; MUTASE; MYELIN PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL MATURATION; CONTROLLED STUDY; EMBRYO; GENE EXPRESSION; GENOTYPE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; KNOCKOUT MOUSE; MALE; MOUSE; MYELINATION; NONHUMAN; NONMYELINATED NERVE; PERIPHERAL NERVE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SCHWANN CELL; SCIATIC NERVE; TRANSMISSION ELECTRON MICROSCOPY; WESTERN BLOTTING; ANIMAL; C57BL MOUSE; CYTOLOGY; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; HEK293 CELL LINE; METABOLISM; MYELIN SHEATH; PHYSIOLOGY; SIGNAL TRANSDUCTION; ULTRASTRUCTURE;

ANIMALS; ARABIDOPSIS PROTEINS; GENE EXPRESSION REGULATION; HEK293 CELLS; HUMANS; INTRAMOLECULAR TRANSFERASES; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROSCOPY, ELECTRON, TRANSMISSION; MYELIN PROTEINS; MYELIN SHEATH; RECEPTORS, PURINERGIC P2X7; SCHWANN CELLS; SCIATIC NERVE; SIGNAL TRANSDUCTION; TRANSFECTION;

EID: 84905899482     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.23417     Document Type: Article

References (47)

1. Arvidsson S, Kwasniewski M, Riano-Pachon DM, Mueller-Roeber B. 2008. QuantPrime-a flexible tool for reliable high-throughput primer design for quantitative PCR. BMC Bioinformatics 9:465.
2. Baron P, Shy M, Honda H, Sessa M, Kamholz J, Pleasure D. 1994. Developmental expression of P0 mRNA and P0 protein in the sciatic nerve and the spinal nerve roots of the rat. J Neurocytol 23:249-257.
3. 7R-/- mice: evidence for loss of apoptotic activity in lymphocytes. J Immunol 176:3115-3126.
4. Chen ZL, Yu WM, Strickland S. 2007. Peripheral regeneration. Annu Rev Neurosci 30:209-233.
5. 7 purinoceptor gene abolishes chronic inflammatory and neuropathic pain. Pain 114:386-396.
6. 7 antagonist, oxidized ATP, in arthritic rats. Neurosci Lett 327:87-90.
7. de Rivero Vaccari JP, Bastien D, Yurcisin G, Pineau I, Dietrich WD, De Koninck Y, Keane RW, Lacroix S. 2012. P2X4 receptors influence inflammasome activation after spinal cord injury. J Neurosci 32:3058-3066.
8. Faroni A, Rothwell SW, Grolla AA, Terenghi G, Magnaghi V, Verkhratsky A. 2013. Differentiation of adipose-derived stem cells into Schwann cell phenotype induces expression of P2X receptors that control cell death. Cell Death Dis 4:e743.
9. Faroni A, Castelnovo LF, Procacci P, Caffino L, Fumagalli F, Melfi S, Gambarotta G, Bettler B, Wrabetz L, Magnaghi V. 2014. Deletion of GABA-B receptor in Schwann cells regulates remak bundles and small nociceptive C-fibers. Glia 62:548-565.
10. Fields RD. 2008. White matter in learning, cognition and psychiatric disorders. Trends Neurosci 31:361-370.
11. Fields RD, Stevens-Graham B. 2002. New insights into neuron-glia communication. Science 298:556-562.
12. Garbay B, Fournier M, Sallafranque ML, Muller S, Boiron F, Heape A, Cassagne C, Bonnet J. 1988. Po, MBP, histone, and DNA levels in sciatic nerve. Postnatal accumulation studies in normal and trembler mice. Neurochem Pathol 8:91-107.
13. Garbay B, Domec C, Fournier M, Bonnet J. 1989. Developmental expression of the P0 glycoprotein and basic protein mRNAs in normal and trembler mutant mice. J Neurochem 53:907-911.
14. Grafe P, Mayer C, Takigawa T, Kamleiter M, Sanchez-Brandelik R. 1999. Confocal calcium imaging reveals an ionotropic P2 nucleotide receptor in the paranodal membrane of rat Schwann cells. J Physiol 515:377-383.
15. Greenbaum D, Colangelo C, Williams K, Gerstein M. 2003. Comparing protein abundance and mRNA expression levels on a genomic scale. Genome Biol 4:117.
16. Hartline DK, Colman DR. 2007. Rapid conduction and the evolution of giant axons and myelinated fibers. Curr Biol 17:R29-R35.
17. Hansen RR, Nielsen CK, Nasser A, Thomsen SI, Eghorn LF, Pham Y, Schulenburg C, Syberg S, Ding M, Stojilkovic SS, Jorgensen NR, Heegaard AM. 2011. P2X7 receptor-deficient mice are susceptible to bone cancer pain. Pain 152:1766-1776.
18. 7 receptor antagonist, dose-dependently reduces neuropathic pain in the rat. J Pharmacol Exp Ther 319:1376-1385.
19. Huxley AF, Stampfli R. 1949. Evidence for saltatory conduction in peripheral myelinated nerve fibres. J Physiol 108:315-339.
20. Jahromi BS, Robitaille R, Charlton MP. 1992. Transmitter release increases intracellular calcium in perisynaptic Schwann cells in situ. Neuron 8:1069-1077.
21. Jessen KR, Mirsky R. 2005. The origin and development of glial cells in peripheral nerves. Nat Rev Neurosci 6:671-682.
22. 7 purinoceptors contribute to the death of Schwann cells transplanted into the spinal cord. Cell Death Dis 4:e829.
23. Lynn B, Carpenter SE. 1982. Primary afferent units from the hairy skin of the rat hind limb. Brain Res 238:29-43.
24. Magnaghi V, Cavarretta I, Galbiati M, Martini L, Melcangi RC. 2001. Neuroactive steroids and peripheral myelin proteins. Brain Res Brain Res Rev 37:360-371.
25. Magnaghi V, Ballabio M, Camozzi F, Colleoni M, Consoli A, Gassmann M, Lauria G, Motta M, Procacci P, Trovato AE, Bettler B. 2008. Altered peripheral myelination in mice lacking GABAB receptors. Mol Cell Neurosci 37:599-609.
26. Magnaghi V, Procacci P, Tata AM. 2009. Novel pharmacological approaches to Schwann cells as neuroprotective agents for peripheral nerve regeneration. Int Rev Neurobiol 87:295-315.
27. Martucci C, Trovato AE, Costa B, Borsani E, Franchi S, Magnaghi V, Panerai AE, Rodella LF, Valsecchi AE, Sacerdote P, Colleoni M. 2008. The purinergic antagonist PPADS reduces pain related behaviours and interleukin-1 beta, interleukin-6, iNOS and nNOS overproduction in central and peripheral nervous system after peripheral neuropathy in mice. Pain 137:81-95.
28. 7 receptors in oligodendrocytes: a novel target for neuroprotection. Mol Neurobiol 38:123-128.
29. Mayhew TM, Sharma AK. 1984. Sampling schemes for estimating nerve fibre size. I. Methods for nerve trunks of mixed fascicularity. J Anat 139 :45-58.
30. Meyer zu Horste G, Prukop T, Nave KA, Sereda MW. 2006. Myelin disorders: causes and perspectives of Charcot-Marie-Tooth neuropathy. J Mol Neurosci 28:77-88.
31. Newman S, Kitamura K, Campagnoni AT. 1987. Identification of a cDNA coding for a fifth form of myelin basic protein in mouse. Proc Natl Acad Sci U S A 84:886-890.
32. Niemann S, Sereda MW, Rossner M, Stewart H, Suter U, Meinck HM, Griffiths IR, Nave KA. 1999. The "CMT rat": peripheral neuropathy and dysmyelination caused by transgenic overexpression of PMP22. Ann N Y Acad Sci 883:254-261.
33. 7-mediated increased intracellular calcium causes functional derangement in Schwann cells from rats with CMT1A neuropathy. J Biol Chem 284:23146-23158.
34. Patzig J, Jahn O, Tenzer S, Wichert SP, de Monasterio-Schrader P, Rosfa S, Kuharev J, Yan K, Bormuth I, Bremer J, Aguzzi A, Orfaniotou F, Hesse D, Schwab MH, Mobius W, Nave KA, Werner HB. 2011. Quantitative and integrative proteome analysis of peripheral nerve myelin identifies novel myelin proteins and candidate neuropathy loci. J Neurosci 31:16369-16386.
35. 7 improves recovery after spinal cord injury. Proc Natl Acad Sci U S A 106:12489-12493.
36. Sharp AJ, Polak PE, Simonini V, Lin SX, Richardson JC, Bongarzone ER, Feinstein DL. 2008. P2x7 deficiency suppresses development of experimental autoimmune encephalomyelitis. J Neuroinflamm 5:33.
37. Sheean ME, McShane E, Cheret C, Walcher J, Muller T, Wulf-Goldenberg A, Hoelper S, Garratt AN, Kruger M, Rajewsky K, Meijer D, Birchmeier W, Lewin GR, Selbach M, Birchmeier C. 2014. Activation of MAPK overrides the termination of myelin growth and replaces Nrg1/ErbB3 signals during Schwann cell development and myelination. Genes Dev 28:290-303.
38. Sherman DL, Brophy PJ. 2005. Mechanisms of axon ensheathment and myelin growth. Nat Rev Neurosci 6:683-690.
39. 7 receptor expression in rodent brain. J Neurosci 24:6307-6314.
40. Solle M, Labasi J, Perregaux DG, Stam E, Petrushova N, Koller BH, Griffiths RJ, Gabel CA. 2001. Altered cytokine production in mice lacking P2X(7) receptors. J Biol Chem 276:125-132.
41. Stahl N, Harry J, Popko B. 1990. Quantitative analysis of myelin protein gene expression during development in the rat sciatic nerve. Brain Res Mol Brain Res 8:209-212.
42. Stevens B, Fields RD. 2000. Response of Schwann cells to action potentials in development. Science 287:2267-2271.
43. Stevens B, Tanner S, Fields RD. 1998. Control of myelination by specific patterns of neural impulses. J Neurosci 18:9303-9311.
44. Taveggia C, Zanazzi G, Petrylak A, Yano H, Rosenbluth J, Einheber S, Xu X, Esper RM, Loeb JA, Shrager P, Chao MV, Falls DL, Role L, Salzer JL. 2005. Neuregulin-1 type III determines the ensheathment fate of axons. Neuron 47:681-694.
45. 7 receptor inhibition improves recovery after spinal cord injury. Nat Med 10:821-827.
46. Xu WB, Manichella D, Jiang HY, Vallat JM, Lilien J, Baron P, Scarlato G, Kamholz S, Shy ME. 2000. Absence of P0 leads to the dysregulation of myelin gene expression and myelin morphogenesis. J Neurosci Res 60:714-724.
47. Yin X, Crawford TO, Griffin JW, Tu P, Lee VM, Li C, Roder J, Trapp BD. 1998. Myelin-associated glycoprotein is a myelin signal that modulates the caliber of myelinated axons. J Neurosci 18:1953-1962.